Beaumont Financial Advisors LLC Sells 743 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Beaumont Financial Advisors LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,776 shares of the financial services provider’s stock after selling 743 shares during the period. Beaumont Financial Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,328,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Glass Jacobson Investment Advisors llc grew its position in iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after buying an additional 122 shares in the last quarter. PCA Investment Advisory Services Inc. acquired a new stake in iShares Biotechnology ETF during the second quarter worth about $28,000. Values First Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth about $43,000. Tennessee Valley Asset Management Partners acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth about $44,000. Finally, Horizon Bancorp Inc. IN acquired a new stake in iShares Biotechnology ETF during the third quarter worth about $44,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.1 %

NASDAQ IBB opened at $124.72 on Friday. The stock’s 50 day moving average is $135.09 and its two-hundred day moving average is $129.54. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.